Keyphrases
Dendritic Cells
100%
XCR1
85%
Nonalcoholic Steatohepatitis
85%
Liver Pathology
85%
Tumor Microenvironment
53%
Single-cell RNA Sequencing (scRNA-seq)
50%
T Cells
47%
Temporal Response
42%
Treatment Protocol
42%
Cancer Immunotherapy
42%
Combinational Therapy
42%
Multiple Myeloma Patients
42%
Relapsed or Refractory multiple Myeloma
42%
Therapeutic Target
42%
Conversion Error
42%
Multiple Myeloma
42%
Lgr5
42%
Scleroderma
42%
Skin Fibroblasts
42%
Resistance Pathways
42%
Erythropoietin
42%
TrkB
42%
Alzheimer's Disease Model
42%
Neuroinflammation
42%
Chronic Stress
42%
Solid Tumors
42%
Tumor-associated Macrophages
42%
Chimeric Antigen Receptor T Cells (CAR-T)
42%
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
42%
Tumor Antigen
42%
Macrophages
42%
Antigen-independent
42%
Prolyl Isomerase
34%
Tumor-draining Lymph Nodes
29%
Tumor-specific
28%
Anti-PD-1 Therapy
28%
CDC1
27%
5xFAD
25%
Tumor
22%
Fibroblasts
21%
Interleukin-12 (IL-12)
21%
Chimeric Antigen Receptor T-cell Therapy
21%
Mouse Model
18%
Autoimmune Disease
17%
Newly Diagnosed multiple Myeloma
17%
Protein Folding
17%
Alzheimer's Disease
17%
Cognitive Aspects
17%
System Level
14%
Tumor Control
14%
Immunology and Microbiology
Dendritic Cell
57%
T Cell
51%
Dynamics
47%
Cancer Immunotherapy
42%
Precursor
42%
Single-Cell Sequencing
42%
Multiple Myeloma
42%
Steatohepatitis
42%
XCR1
42%
Scleroderma
42%
Skin Fibroblast
42%
Chimeric Antigen Receptor T-Cell
42%
Tumor-Associated Macrophage
42%
Tumor Antigen
42%
Macrophage
42%
Lymph Node
29%
Immunotherapy
28%
Fibroblast
28%
Chimeric Antigen Receptor T-Cell Therapy
21%
Chimeric Antigen Receptor
21%
Immunosuppressive Drug
21%
Mouse Model
18%
Autoimmune Disease
17%
Cytotoxic T-Cell
14%
Programmed Death 1 Receptor
14%
Agonist
14%
CD8+ Cell
14%
Immunity
11%
Cell Infiltration
10%
Transgenics
10%
Natural Killer Cell
10%
Secretion (Process)
10%
Cell Activation
10%
NFAT
10%
In Vitro
10%
Immunoglobulin Producing Cell
8%
Protein Folding
8%
RNA Sequence
8%
Non-Alcoholic Fatty Liver Disease
8%
Systemic Scleroderma
7%
Mortality Rate
7%
Morbidity
7%
Morphology
7%
Transcription Factors
7%
